CLINICAL_TRIALS
trial_result
· 2021-11-11
Clinical Trial Update: Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis [Phase 4]
Summary
Phase 4 trial updating intravenous dose optimization of vedolizumab in ulcerative colitis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Colitis, Ulcerative | Phase 4 | Status: COMPLETED | Results posted: 2021-11-11